Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Feasibility Study of Sorafenib and Gemcitabine Combination Treatment in Patients With Advanced Hepatocellular Carcinoma

NCT00844688 is registered in ClinicalTrials.gov with Combined Military Hospital, Pakistan as lead sponsor.

NCT NCT00844688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00844688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Feasibility Study of Sorafenib and Gemcitabine Combination Treatment in Patients With Advanced Hepatocellular Carcinoma
Lead sponsor
Combined Military Hospital, Pakistan
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2008
Completion date
December 31, 2009
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma